MedTech Terms
    The authoritative reference
    All terms

    Field Action vs Recall

    Distinction between corrective field actions taken on devices in the field and FDA-defined recall events.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Not every field action is a recall under 21 CFR 7. Service updates, customer notifications, and minor labeling additions may not meet the recall definition - but FDA distinguishes 'corrections' and 'removals' under 21 CFR 806 reporting separately from recalls under Part 7.
    What the regulation says
    The FDA defines a recall in 21 CFR Part 7 as a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action. Separately, 21 CFR Part 806 requires medical device manufacturers to report to the FDA certain corrections and removals of medical devices, irrespective of being a recall action. Per ISO 13485:2016 clause 8.2.1, feedback from post-production activities, including field actions, must be used to improve product and service quality.

    What this means in practice

    Misclassifying an action as 'not a recall' to avoid public reporting is a recurring enforcement target.

    Examples

    • A medical device manufacturer issues a software update to improve cybersecurity features; this is a field action but likely not a recall.
    • A company discovers a design flaw in its implantable cardiac device that could lead to serious injury or death; this would likely trigger a Class I recall per 21 CFR 7.3.
    • A manufacturer sends a letter to customers clarifying an ambiguity in user instructions for a diagnostic test; this is a correction under 21 CFR 806, but may not be a recall.
    Common pitfalls
    • •Misclassifying a recall as a less severe field action to avoid public scrutiny can lead to significant regulatory penalties and reputational damage.
    • •Failing to establish clear internal procedures for distinguishing between different types of field actions and recalls can result in inconsistent regulatory reporting.
    • •Assuming that a 'correction' or 'removal' under 21 CFR 806 is automatically a recall under 21 CFR Part 7 can lead to over-reporting or misapplication of regulatory requirements.

    Frequently asked questions

    A recall, as defined by the FDA in 21 CFR Part 7, is a specific type of field action involving regulated products that violate FDA law. Field actions encompass a broader range of activities including corrections, removals, and other notifications that may or may not meet the strict definition of a recall.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    eCFR·1FDA·1European Commission·1
    1. 1
      21 CFR 806
      Verified
      eCFRecfr.gov
    2. 2
      FDA Recalls - Medical Devices
      Verified
      FDAfda.gov
    3. 3
      EUDAMED Public Site
      Verified
      European Commissionec.europa.eu

    Inline markers like [1] jump to the matching reference above.